5AM Venture Management, LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001799883 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $458M (100.0% shares, 0.0% debt)

Holdings (19)

— PEAR THERAPEUTICS INC 20.6%

Value $94.09M Shares 18,631,771 Est. Cost $6.20 Unrealized —

— CINCOR PHARMA INC 16.6%

Value $76.08M Shares 4,337,646 Est. Cost $17.54 Unrealized —

TRDA ENTRADA THERAPEUTICS INC 9.0%

Value $41.4M Shares 4,408,379 Est. Cost $17.12 Unrealized —

— VOR BIOPHARMA INC 8.4%

Value $38.42M Shares 6,361,723 Est. Cost $43.10 Unrealized —

— RALLYBIO CORP 6.1%

Value $27.79M Shares 3,980,724 Est. Cost $17.58 Unrealized —

ARVN ARVINAS INC 5.9%

Value $26.92M Shares 400,000 Est. Cost $29.28 Unrealized +132.8%

— SCPHARMACEUTICALS INC 4.8%

Value $21.76M Shares 3,831,474 Est. Cost $5.92 Unrealized —

— AKOUOS INC 4.3%

Value $19.64M Shares 4,135,784 Est. Cost $22.50 Unrealized —

CRNX CRINETICS PHARMACEUTICALS IN 4.1%

Value $18.93M Shares 862,286 Est. Cost $19.04 Unrealized +6.3%

— IMPEL NEUROPHARMA INC 4.0%

Value $18.38M Shares 2,884,791 Est. Cost $8.85 Unrealized —

— IVERIC BIO INC 3.8%

Value $17.3M Shares 1,027,874 Est. Cost $16.46 Unrealized —

IDYA IDEAYA BIOSCIENCES INC 3.4%

Value $15.64M Shares 1,398,066 Est. Cost $7.13 Unrealized +106.6%

— HOMOLOGY MEDICINES INC 3.0%

Value $13.79M Shares 4,535,919 Est. Cost $20.70 Unrealized —

RNAM AVIDITY BIOSCIENCES INC 1.6%

Value $7.214M Shares 390,555 Est. Cost $21.74 Unrealized -21.8%

JANX JANUX THERAPEUTICS INC 1.4%

Value $6.399M Shares 446,266 Est. Cost $22.27 Unrealized -26.5%

COGT COGENT BIOSCIENCES INC 1.2%

Value $5.328M Shares 711,412 Est. Cost $6.96 Unrealized 0.0%

CABA CABALETTA BIO INC 0.9%

Value $4.19M Shares 2,064,263 Est. Cost $11.85 Unrealized -77.9%

— 5 01 ACQUISITION CORP 0.8%

Value $3.596M Shares 365,126 Est. Cost $10.17 Unrealized —

— CIDARA THERAPEUTICS INC 0.2%

Value $945K Shares 1,134,511 Est. Cost $3.84 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	PEAR THERAPEUTICS INC	18,631,771	$94.09M	20.6%	$6.20	—	CLASS A COM	704723105
—	CINCOR PHARMA INC	4,337,646	$76.08M	16.6%	$17.54	—	COM	17240Y109
TRDA	ENTRADA THERAPEUTICS INC	4,408,379	$41.4M	9.0%	$17.12	—	COM	29384C108
—	VOR BIOPHARMA INC	6,361,723	$38.42M	8.4%	$43.10	—	COM	929033108
—	RALLYBIO CORP	3,980,724	$27.79M	6.1%	$17.58	—	COM	75120L100
ARVN	ARVINAS INC	400,000	$26.92M	5.9%	$29.28	+132.8%	COM	04335A105
—	SCPHARMACEUTICALS INC	3,831,474	$21.76M	4.8%	$5.92	—	COM	810648105
—	AKOUOS INC	4,135,784	$19.64M	4.3%	$22.50	—	COM	00973J101
CRNX	CRINETICS PHARMACEUTICALS IN	862,286	$18.93M	4.1%	$19.04	+6.3%	COM	22663K107
—	IMPEL NEUROPHARMA INC	2,884,791	$18.38M	4.0%	$8.85	—	COM	45258K109
—	IVERIC BIO INC	1,027,874	$17.3M	3.8%	$16.46	—	COM	46583P102
IDYA	IDEAYA BIOSCIENCES INC	1,398,066	$15.64M	3.4%	$7.13	+106.6%	COM	45166A102
—	HOMOLOGY MEDICINES INC	4,535,919	$13.79M	3.0%	$20.70	—	COM	438083107
RNAM	AVIDITY BIOSCIENCES INC	390,555	$7.214M	1.6%	$21.74	-21.8%	COM	05370A108
JANX	JANUX THERAPEUTICS INC	446,266	$6.399M	1.4%	$22.27	-26.5%	COM	47103J105
COGT	COGENT BIOSCIENCES INC	711,412	$5.328M	1.2%	$6.96	0.0%	COM	19240Q201
CABA	CABALETTA BIO INC	2,064,263	$4.19M	0.9%	$11.85	-77.9%	COM	12674W109
—	5 01 ACQUISITION CORP	365,126	$3.596M	0.8%	$10.17	—	COM CL A	33836P105
—	CIDARA THERAPEUTICS INC	1,134,511	$945K	0.2%	$3.84	—	COM	171757107